{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33029165", "DateRevised": {"Year": "2024", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "30"}], "Language": ["eng"], "ELocationID": ["4932572", "10.1155/2020/4932572"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Investigating Potential Inhibitory Effect of <i>Uncaria tomentosa</i> (Cat's Claw) against the Main Protease 3CL<sup>pro</sup> of SARS-CoV-2 by Molecular Modeling.", "Pagination": {"StartPage": "4932572", "MedlinePgn": "4932572"}, "Abstract": {"AbstractText": ["COVID-19 is a disease caused by severe acute respiratory syndrome coronavirus 2. Presently, there is no effective treatment for COVID-19. As part of the worldwide efforts to find efficient therapies and preventions, it has been reported the crystalline structure of the SARS-CoV-2 main protease M<sup>pro</sup> (also called 3CL<sup>pro</sup>) bound to a synthetic inhibitor, which represents a major druggable target. The druggability of M<sup>pro</sup> could be used for discovering drugs to treat COVID-19. A multilevel computational study was carried out to evaluate the potential antiviral properties of the components of the medicinal herb <i>Uncaria tomentosa</i> (Cat's claw), focusing on the inhibition of M<sup>pro</sup>. The <i>in silico</i> approach starts with protein-ligand docking of 26 Cat's claw key components, followed by ligand pathway calculations, molecular dynamics simulations, and MM-GBSA calculation of the free energy of binding for the best docked candidates. The structural bioinformatics approaches led to identification of three bioactive compounds of <i>Uncaria tomentosa</i> (speciophylline, cadambine, and proanthocyanidin B2) with potential therapeutic effects by strong interaction with 3CL<sup>pro</sup>. Additionally, <i>in silico</i> drug-likeness indices for these components were calculated and showed good predicted therapeutic profiles of these phytochemicals. Our findings suggest the potential effectiveness of Cat's claw as complementary and/or alternative medicine for COVID-19 treatment."], "CopyrightInformation": "Copyright \u00a9 2020 Andres F. Yepes-P\u00e9rez et al."}, "AuthorList": [{"Identifier": ["0000-0001-6975-5119"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Colombian Plants, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia-UdeA, Calle 70 No. 52-21, A.A 1226, Medellin, Colombia."}], "LastName": "Yepes-P\u00e9rez", "ForeName": "Andres F", "Initials": "AF"}, {"Identifier": ["0000-0001-7264-0961"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academic Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Jr Puno 1002, Lima 15001, Peru."}], "LastName": "Herrera-Calderon", "ForeName": "Oscar", "Initials": "O"}, {"Identifier": ["0000-0002-3397-8393"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Insilichem, Departament de Qu\u00edmica, Universitat Aut\u00f2noma de Barcelona, Edifici C.n., 08193 Cerdanyola del Vall\u00e9s, Barcelona, Spain."}], "LastName": "S\u00e1nchez-Aparicio", "ForeName": "Jos\u00e9-Emilio", "Initials": "JE"}, {"Identifier": ["0000-0002-6344-9839"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Insilichem, Departament de Qu\u00edmica, Universitat Aut\u00f2noma de Barcelona, Edifici C.n., 08193 Cerdanyola del Vall\u00e9s, Barcelona, Spain."}], "LastName": "Tiessler-Sala", "ForeName": "Laura", "Initials": "L"}, {"Identifier": ["0000-0002-8344-9043"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Insilichem, Departament de Qu\u00edmica, Universitat Aut\u00f2noma de Barcelona, Edifici C.n., 08193 Cerdanyola del Vall\u00e9s, Barcelona, Spain."}], "LastName": "Mar\u00e9chal", "ForeName": "Jean-Didier", "Initials": "JD"}, {"Identifier": ["0000-0002-5374-1211"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Colombian Plants, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia-UdeA, Calle 70 No. 52-21, A.A 1226, Medellin, Colombia."}], "LastName": "Cardona-G", "ForeName": "Wilson", "Initials": "W"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Singhal T. A review of coronavirus disease-2019 (COVID-19) Indian Journal of Pediatrics. 2020;87(4):281\u2013286.", "ArticleIdList": ["PMC7090728", "32166607"]}, {"Citation": "Chen Y. W., Yiu C. P. B., Wong K. Y. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000 Research. 2020;9:p. 129.", "ArticleIdList": ["PMC7062204", "32194944"]}, {"Citation": "Wang C., Horby P. W., Hayden F. G., Gao G. F. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395(10223):470\u2013473. doi: 10.1016/s0140-6736(20)30185-9.", "ArticleIdList": ["10.1016/s0140-6736(20)30185-9", "PMC7135038", "31986257"]}, {"Citation": "Williamson J., Ramirez R., Wingfield T. Health, healthcare access, and use of traditional versus modern medicine in remote Peruvian Amazon communities: a descriptive study of knowledge, attitudes, and practices. The American Journal of Tropical Medicine and Hygiene. 2015;92(4):857\u2013864. doi: 10.4269/ajtmh.14-0536.", "ArticleIdList": ["10.4269/ajtmh.14-0536", "PMC4385786", "25688165"]}, {"Citation": "Bussmann R. W., Malca-Garc\u00eda G., Glenn A., et al. Minimum inhibitory concentrations of medicinal plants used in Northern Peru as antibacterial remedies. Journal of Ethnopharmacology. 2010;132(1):101\u2013108. doi: 10.1016/j.jep.2010.07.048.", "ArticleIdList": ["10.1016/j.jep.2010.07.048", "PMC2956840", "20678568"]}, {"Citation": "Ben-Shabat S., Yarmolinsky L., Porat D., Dahan A. Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies. Drug Delivery and Translational Research. 2020;10(2):354\u2013367. doi: 10.1007/s13346-019-00691-6.", "ArticleIdList": ["10.1007/s13346-019-00691-6", "PMC7097340", "31788762"]}, {"Citation": "Herrera-Calderon O., Arroyo-Acevedo J. L., Rojas-Armas J., et al. Phytochemical screening, total phenolic content, antioxidant and cytotoxic activity of chromolaena laevigata on human tumor cell lines. Annual Research & Review in Biology. 2017;21(1):1\u20139. doi: 10.9734/arrb/2017/37045.", "ArticleIdList": ["10.9734/arrb/2017/37045"]}, {"Citation": "Heitzman M. E., Neto C. C., Winiarz E., Vaisberg A. J., Hammond G. B. Ethnobotany, phytochemistry and pharmacology of uncaria (Rubiaceae) ChemInform. 2005;36(17) doi: 10.1002/chin.200517286.", "ArticleIdList": ["10.1002/chin.200517286", "15649507"]}, {"Citation": "Keplinger K., Laus G., Wurm M., Dierich M. P., Teppner H. Uncaria tomentosa (Willd.) DC.\u2014ethnomedicinal use and new pharmacological, toxicological and botanical results. Journal of Ethnopharmacology. 1998;64(1):23\u201334. doi: 10.1016/s0378-8741(98)00096-8.", "ArticleIdList": ["10.1016/s0378-8741(98)00096-8", "10075119"]}, {"Citation": "Gonzales G. F., Aguilar J., Villar M. The world summit of harmonization on traditional, alternative and complementary medicine (TACM) in Lima, Peru. Evidence-based Complementary and Alternative Medicine. 2010;7(2):271\u2013275. doi: 10.1093/ecam/nen042.", "ArticleIdList": ["10.1093/ecam/nen042", "PMC2862939", "18955348"]}, {"Citation": "Ko\u015bmider A., Czepielewska E., Kura\u015b M., et al. Uncaria tomentosa leaves decoction modulates differently ROS production in cancer and normal cells, and effects cisplatin cytotoxicity. Molecules. 2017;22(4):p. 620. doi: 10.3390/molecules22040620.", "ArticleIdList": ["10.3390/molecules22040620", "PMC6154711", "28417940"]}, {"Citation": "Zhu S., Li Q., Chen S., et al. Phylogenetic analysis of Uncaria species based on internal transcribed spacer (ITS) region and ITS2 secondary structure. Pharmaceutical Biology. 2018;56(1):548\u2013558. doi: 10.1080/13880209.2018.1499780.", "ArticleIdList": ["10.1080/13880209.2018.1499780", "PMC6225500", "30392423"]}, {"Citation": "Snow A. D., Castillo G. M., Nguyen B. P., et al. The Amazon rain forest plant Uncaria tomentosa (cat\u2019s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles. Scientific Reports. 2019;9(1) doi: 10.1038/s41598-019-38645-0.", "ArticleIdList": ["10.1038/s41598-019-38645-0", "PMC6365538", "30728442"]}, {"Citation": "Laus G., Br\u00f6ssner D., Keplinger K. Alkaloids of Peruvian Uncaria tomentosa. Phytochemistry. 1997;45(4):855\u2013860. doi: 10.1016/s0031-9422(97)00061-7.", "ArticleIdList": ["10.1016/s0031-9422(97)00061-7"]}, {"Citation": "Vera-Reyes I., Huerta-Heredia A. A., Ponce-Noyola T., et al. Monoterpenoid indole alkaloids and phenols are required antioxidants in glutathione depleted Uncaria tomentosa root cultures. Frontiers in Environmental Science. 2015;3 doi: 10.3389/fenvs.2015.00027.", "ArticleIdList": ["10.3389/fenvs.2015.00027"]}, {"Citation": "Montoro P., Carbone V., de Dioz Zuniga Quiroz J., De Simone F., Pizza C. Identification and quantification of components in extracts of Uncaria tomentosa by HPLC-ES/MS. Phytochemical Analysis. 2004;15(1):55\u201364.", "ArticleIdList": ["14979528"]}, {"Citation": "Aquino R., De Tommasi N., De Simone F., Pizza C. Triterpenes and quinovic acid glycosides from Uncaria tomentosa. Phytochemistry. 1997;45(5):1035\u20131040. doi: 10.1016/s0031-9422(96)00716-9.", "ArticleIdList": ["10.1016/s0031-9422(96)00716-9"]}, {"Citation": "Cerri R., Aquino R., De Simone F., Pizza C. New quinovic acid glycosides from Uncaria tomentosa. Journal of Natural Products. 1988;51(2):257\u2013261. doi: 10.1021/np50056a010.", "ArticleIdList": ["10.1021/np50056a010", "2553871"]}, {"Citation": "Pe\u00f1aloza E. M. C., Kaiser S., De Resende P. E., et al. Chemical composition variability in the Uncaria tomentosa (cat\u2019s claw) wild population. Qu\u00edmica Nova. 2015;38(3)"}, {"Citation": "Hoyos M. N., S\u00e1nchez-Pat\u00e1n F., Masis R. M., et al. Phenolic assessment of Uncaria tomentosa L. (cat\u2019s claw): leaves, stem, bark and wood extracts. Molecules. 2015;20(12):22703\u201322717. doi: 10.3390/molecules201219875.", "ArticleIdList": ["10.3390/molecules201219875", "PMC6332257", "26694348"]}, {"Citation": "Kitajima M., Hashimoto K. I., Yokoya M., Takayama H., Aimi N. Two new 19-hydroxyursolic acid-type triterpenes from Peruvian \u2018Una de Gato\u2019 (Uncaria tomentosa) Tetrahedron. 2000;56(4):547\u2013552. doi: 10.1016/s0040-4020(99)01048-0.", "ArticleIdList": ["10.1016/s0040-4020(99)01048-0"]}, {"Citation": "Y\u00e9pez A. M. P., de Ugaz O. L., Alvarez C. M. P., et al. Quinovic acid glycosides from Uncaria guianensis. Phytochemistry. 1991;30(5):1635\u20131637. doi: 10.1016/0031-9422(91)84223-f.", "ArticleIdList": ["10.1016/0031-9422(91)84223-f", "1367339"]}, {"Citation": "Aquino R., De Simone F., Pizza C., Conti C., Stein M. L. Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda. Journal of Natural Products. 1989;52(4):679\u2013685. doi: 10.1021/np50064a002.", "ArticleIdList": ["10.1021/np50064a002", "2553871"]}, {"Citation": "Yunis Aguinaga J., Claudiano G. S., Marcusso P. F., et al. Acute toxicity and determination of the active constituents of aqueous extract of Uncaria tomentosa bark in Hyphessobrycon eques. Journal of Toxicology. 2014;2014:5. doi: 10.1155/2014/412437.412437", "ArticleIdList": ["10.1155/2014/412437", "PMC3964835", "24734041"]}, {"Citation": "Reis S. R. I. N., Valente L. M. M., Sampaio A. L., et al. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with dengue virus-2. International Immunopharmacology. 2008;8(3):468\u2013476. doi: 10.1016/j.intimp.2007.11.010.", "ArticleIdList": ["10.1016/j.intimp.2007.11.010", "18279801"]}, {"Citation": "Lima-Junior R. S., Da Silva Mello C., Kubelka C. F., Siani A. C., Valente L. M. M. Uncaria tomentosa alkaloidal fraction reduces paracellular permeability, IL-8 and NS1 production on human microvascular endothelial cells infected with dengue virus. Natural Product Communications. 2013;8(11) doi: 10.1177/1934578x1300801112.1934578X1300801", "ArticleIdList": ["10.1177/1934578x1300801112", "24427938"]}, {"Citation": "Caon T., Kaiser S., Feltrin C., et al. Antimutagenic and antiherpetic activities of different preparations from Uncaria tomentosa (cat\u2019s claw) Food and Chemical Toxicology. 2014;66:30\u201335. doi: 10.1016/j.fct.2014.01.013.", "ArticleIdList": ["10.1016/j.fct.2014.01.013", "24447975"]}, {"Citation": "Allen-Hall L., Arnason J. T., Cano P., Lafrenie R. M. Uncaria tomentosa acts as a potent TNF-\u03b1 inhibitor through NF-\u03baB. Journal of Ethnopharmacology. 2010;127(3):685\u2013693. doi: 10.1016/j.jep.2009.12.004.", "ArticleIdList": ["10.1016/j.jep.2009.12.004", "19995599"]}, {"Citation": "Williams J. E. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on u\u00f1a de gato and sangre de grado. Alternative Medicine Review. 2001;6(6):567\u2013579.", "ArticleIdList": ["11804547"]}, {"Citation": "Sandoval M., Charbonnet R. M., Okuhama N. N., et al. Cat\u2019s claw inhibits TNF\u03b1 production and scavenges free radicals: role in cytoprotection. Free Radical Biology and Medicine. 2000;29(1):71\u201378. doi: 10.1016/s0891-5849(00)00327-0.", "ArticleIdList": ["10.1016/s0891-5849(00)00327-0", "10962207"]}, {"Citation": "L\u00f3pez Galera R. M., Ribera Pascuet E., Esteban Mur J. I., Montoro Ronsano J. B., Ju\u00e1rez Gim\u00e9nez J. C. Interaction between cat\u2019s claw and protease inhibitors atazanavir, ritonavir and saquinavir. European Journal of Clinical Pharmacology. 2008;64(12):1235\u20131236. doi: 10.1007/s00228-008-0551-1.", "ArticleIdList": ["10.1007/s00228-008-0551-1", "18712519"]}, {"Citation": "\u00c5kesson C., Pero R. W., Ivars F. C-Med 100\u00ae, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo. Phytomedicine. 2003;10(1):23\u201333. doi: 10.1078/094471103321648629.", "ArticleIdList": ["10.1078/094471103321648629", "12622460"]}, {"Citation": "Chen S. L., Yu H., Luo H. M., et al. Conservation and sustainable use of medicinal plants: problems, progress, and prospects. Chinese Medicine (United Kingdom) 2016;11(1)", "ArticleIdList": ["PMC4967523", "27478496"]}, {"Citation": "Prajapat M., Sarma P., Shekhar N., et al. Drug targets for corona virus: a systematic review. Scholars International Journal of Biochemistry. 2020;3(6):143\u2013153. doi: 10.36348/sijb.2020.v03i06.005.", "ArticleIdList": ["10.36348/sijb.2020.v03i06.005", "PMC7074424", "32201449"]}, {"Citation": "Wu C., Liu Y., Yang Y., et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta pharmaceutica Sinica. B. 2020;10(5):766\u2013788.", "ArticleIdList": ["PMC7102550", "32292689"]}, {"Citation": "Elmezayen A. D., Al-Obaidi A., \u015eahin A. T., Yelek\u00e7i K. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. 2020;1\u201013", "ArticleIdList": ["PMC7189413", "32306862"]}, {"Citation": "Peele K. A., Potla Durthi C., Srihansa T., et al. Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: a computational study. Informatics in Medicine Unlocked. 2020;19 doi: 10.1016/j.imu.2020.10034.100345", "ArticleIdList": ["10.1016/j.imu.2020.10034", "PMC7211761", "32395606"]}, {"Citation": "Morris G. M., Goodsell D. S., Halliday R. S., et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry. 1998;19(14):1639\u20131662. doi: 10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b.", "ArticleIdList": ["10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b"]}, {"Citation": "Wang Q., Zhao Y., Chen X., Hong A. Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 2020:1\u201311. doi: 10.1080/07391102.2020.1817786.", "ArticleIdList": ["10.1080/07391102.2020.1817786", "PMC7544985", "32909528"]}, {"Citation": "Zhang L., Lin D., Sun X., et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368(6489):409\u2013412. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Jin Z., Du X., Xu Y., et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Fintelman-Rodrigues N., Sacramento C. Q., Lima C. R., et al. Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. 2020.", "ArticleIdList": ["PMC7508582", "32759267"]}, {"Citation": "McKee D. L., Sternberg A., Stange U., Laufer S., Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacological Research. 2020;157 doi: 10.1016/j.phrs.2020.104859.104859", "ArticleIdList": ["10.1016/j.phrs.2020.104859", "PMC7189851", "32360480"]}, {"Citation": "Martinez M. A. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrobial Agents and Chemotherapy. 2020;64(5)e00399", "ArticleIdList": ["PMC7179632", "32152082"]}, {"Citation": "Ton A. T., Gentile F., Hsing M., Ban F., Cherkasov A. Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics. 2020;39(8) doi: 10.26434/chemrxiv.11860077.v1.e2000028", "ArticleIdList": ["10.26434/chemrxiv.11860077.v1", "PMC7228259", "32162456"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M. S. Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry. 2020;35(1):145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Haider Z., Subhani M. M., Farooq M. A., et al. In silico discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 using pharmacophore and molecular docking based virtual screening from ZINC database. 2020."}, {"Citation": "ChemAxon. ChemAxon\u2014Software Solutions and Services for Chemistry and Biology (Version 16.10.31) Budapest, Hungary: ChemAxon; 2016."}, {"Citation": "Trott O., Olson A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry. 2010;31(2):455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Schr\u00f6dinger. PyMOL, molecular visualization system. 2018.   https://pymol.org."}, {"Citation": "S\u00e1nchez-Aparicio J. E., Sciortino G., Herrmannsdoerfer D. V., et al. Gpathfinder: identification of ligand-binding pathways by a multi-objective genetic algorithm. International Journal of Molecular Sciences. 2019;20(13):p. 3155. doi: 10.3390/ijms20133155.", "ArticleIdList": ["10.3390/ijms20133155", "PMC6651367", "31261636"]}, {"Citation": "Gonz\u00e1lez-Alem\u00e1n R., Hern\u00e1ndez-Castillo D., Caballero J., Montero-Cabrera L. A. Quality threshold clustering of molecular dynamics: a word of caution. Journal of Chemical Information and Modeling. 2020;60(2):467\u2013472. doi: 10.1021/acs.jcim.9b00558.", "ArticleIdList": ["10.1021/acs.jcim.9b00558", "31532987"]}, {"Citation": "Berman H. M., Westbrook J., Feng Z., et al. The Protein Data Bank (www.rcsb.org) Nucleic Acids Research. 2000;28(1):235\u2013242.", "ArticleIdList": ["PMC102472", "10592235"]}, {"Citation": "Pettersen E. F., Goddard T. D., Huang C. C., et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. Journal of Computational Chemistry. 2004;25(13):1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Song L. F., Lee T. S., Zhu C., York D. M., Merz K. M. Using AMBER18 for relative free energy calculations. Journal of Chemical Information and Modeling. 2019;59(7):3128\u20133135. doi: 10.1021/acs.jcim.9b00105.", "ArticleIdList": ["10.1021/acs.jcim.9b00105", "PMC7371000", "31244091"]}, {"Citation": "Frisch M. J., Trucks G. W., Schlegel H. B., et al. Gaussian 09, Revision B.01. Wallingford, CT, USA: Gaussian, Inc.; 2009."}, {"Citation": "Bayly C. I., Cieplak P., Cornell W. D., Kollman P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. The Journal of Physical Chemistry. 1993;97(40):10269\u201310280. doi: 10.1021/j100142a004.", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Case D. A., Ben-Shalom I. Y., Brozell S. R., et al. Amber 2018. 2018."}, {"Citation": "Eastman P., Swails J., Chodera J. D., et al. OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Computational Biology. 2017;13(7) doi: 10.1371/journal.pcbi.1005659.e1005659", "ArticleIdList": ["10.1371/journal.pcbi.1005659", "PMC5549999", "28746339"]}, {"Citation": "Rodr\u00edguez-Guerra Pedregal J., Alonso-Cotchico L., Velasco-Carneros L., Mar\u00e9chal J.-D. OMMProtocol: a command line application to launch molecular dynamics simulations with OpenMM. 2018."}, {"Citation": "Irvine J. D., Takahashi L., Lockhart K., et al. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences. 1999;88(1):28\u201333. doi: 10.1021/js9803205.", "ArticleIdList": ["10.1021/js9803205", "9874698"]}, {"Citation": " Calculation of Molecular Properties and Bioactivity Score Software, Molinspiration Cheminformatics, 2020,  http://www.molinspiration.com/cgi-bin/properties."}, {"Citation": "Tetko I. V., Poda G. I. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds. Journal of Medicinal Chemistry. 2004;47(23):5601\u20135604. doi: 10.1021/jm049509l.", "ArticleIdList": ["10.1021/jm049509l", "15509156"]}, {"Citation": "Broccatelli F., Salphati L., Plise E., et al. Predicting passive permeability of drug-like molecules from chemical structure: where are we? Molecular Pharmaceutics. 2016;13(12):4199\u20134208. doi: 10.1021/acs.molpharmaceut.6b00836.", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00836", "27806577"]}, {"Citation": "Yang H., Lou C., Sun L., et al. AdmetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35(6):1067\u20131069.", "ArticleIdList": ["30165565"]}, {"Citation": "Flores-S\u00e1nchez I. J., Ortega-L\u00f3pez J., Montes-Horcasitas M. D. C., Ramos-Valdivia A. C. Biosynthesis of sterols and triterpenes in cell suspension cultures of Uncaria tomentosa. Plant and Cell Physiology. 2002;43(12):1502\u20131509. doi: 10.1093/pcp/pcf181.", "ArticleIdList": ["10.1093/pcp/pcf181", "12514247"]}, {"Citation": "Navarro M., Zamora W., Quesada S., et al. Fractioning of proanthocyanidins of Uncaria tomentosa. Composition and structure-bioactivity relationship. Antioxidants. 2017;6(3):p. 60. doi: 10.3390/antiox6030060.", "ArticleIdList": ["10.3390/antiox6030060", "PMC5618088", "28788071"]}, {"Citation": "Navarro M., Arnaez E., Moreira I., et al. Polyphenolic composition and antioxidant activity of Uncaria tomentosa commercial bark products. Antioxidants. 2019;8(9):p. 339. doi: 10.3390/antiox8090339.", "ArticleIdList": ["10.3390/antiox8090339", "PMC6770501", "31450810"]}, {"Citation": "Santos Ara\u00fajo M. D. C., Farias I. L., Gutierres J., et al. Uncaria tomentosa\u2014adjuvant treatment for breast cancer: clinical trial. Evidence-Based Complementary and Alternative Medicine. 2012;2012:8. doi: 10.1155/2012/676984.676984", "ArticleIdList": ["10.1155/2012/676984", "PMC3395261", "22811748"]}, {"Citation": "De Paula L. C. L., Fonseca F., Perazzo F., et al. Uncaria tomentosa (Cat\u2019s claw) improves quality of life in patients with advanced solid tumors. The Journal of Alternative and Complementary Medicine. 2015;21(1):22\u201330. doi: 10.1089/acm.2014.0127.", "ArticleIdList": ["10.1089/acm.2014.0127", "25495394"]}, {"Citation": "Gon\u00e7alves C., Dinis T., Batista M. T. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry. 2005;66(1):89\u201398. doi: 10.1016/j.phytochem.2004.10.025.", "ArticleIdList": ["10.1016/j.phytochem.2004.10.025", "15649515"]}, {"Citation": "Lock O., Perez E., Villar M., Flores D., Rojas R. Bioactive compounds from plants used in Peruvian traditional medicine. Natural Product Communications. 2016;11(3):315\u2013337.", "ArticleIdList": ["27169179"]}, {"Citation": "Brown R. T., Duckworth D. M., Santos C. A. M. Biogenetically patterned synthesis of cadambine. Tetrahedron Letters. 1991;32(17):1987\u20131990. doi: 10.1016/0040-4039(91)85020-6.", "ArticleIdList": ["10.1016/0040-4039(91)85020-6"]}, {"Citation": "Pierrot D., Sinou V., Bun S. S., et al. Design and synthesis of simplified speciophylline analogues and \u03b2-carbolines as active molecules against Plasmodium falciparum. Drug Development Research. 2019;80(1):133\u2013137. doi: 10.1002/ddr.21494.", "ArticleIdList": ["10.1002/ddr.21494", "30499121"]}, {"Citation": "Fujii W., Toda K., Matsumoto K., et al. Syntheses of prodelphinidin B1, B2, and B4 and their antitumor activities against human PC-3 prostate cancer cell lines. Tetrahedron Letters. 2013;54(52):7188\u20137192. doi: 10.1016/j.tetlet.2013.10.113.", "ArticleIdList": ["10.1016/j.tetlet.2013.10.113"]}, {"Citation": "Rasoanaivo P., Wright C. W., Willcox M. L., Gilbert B. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria Journal. 2011;10(S1) doi: 10.1186/1475-2875-10-s1-s4.", "ArticleIdList": ["10.1186/1475-2875-10-s1-s4", "PMC3059462", "21411015"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. 2020."}, {"Citation": "Navan C. Possible drug candidates for COVID-19. 2020."}, {"Citation": "Gao K., Nguyen D. D., Wang R., Wei G.-W. Machine intelligence design of 2019-nCoV drugs. 2020."}, {"Citation": "Mittal L., Kumari A., Srivastava M., Singh M., Asthana S. Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics. 2020:1\u201319. doi: 10.1080/07391102.2020.1768151.", "ArticleIdList": ["10.1080/07391102.2020.1768151", "PMC7256355", "32396769"]}, {"Citation": "Kumar Y., Singh H., Patel C. N. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health. 2020;13(9):1210\u20131223. doi: 10.1016/j.jiph.2020.06.016.", "ArticleIdList": ["10.1016/j.jiph.2020.06.016", "PMC7297718", "32561274"]}, {"Citation": "Wang X., Dhindsa R. S., Povysil G., et al. Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2. 2020."}, {"Citation": "Amawi H., Abu Deiab G. I., Aljabali A. A. A., Dua K., Tambuwala M. M. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Therapeutic Delivery. 2020;11(4):245\u2013268. doi: 10.4155/tde-2020-0035.", "ArticleIdList": ["10.4155/tde-2020-0035", "PMC7222554", "32397911"]}, {"Citation": "Lipson S. M., Karalis G., Karthikeyan L., et al. Mechanism of anti-rotavirus synergistic activity by epigallocatechin gallate and a proanthocyanidin-containing nutraceutical. Food and Environmental Virology. 2017;9(4):434\u2013443. doi: 10.1007/s12560-017-9299-z.", "ArticleIdList": ["10.1007/s12560-017-9299-z", "28466464"]}, {"Citation": "Lupala C. S., Li X., Lei J., et al. Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein. 2020."}, {"Citation": "Eastman P., Pande V. S. OpenMM: a hardware-independent framework for molecular simulations. Computing in Science & Engineering. 2010;12(4):34\u201339. doi: 10.1109/mcse.2010.27.", "ArticleIdList": ["10.1109/mcse.2010.27", "PMC4486654", "26146490"]}, {"Citation": "Alonso-Cotchico L., Pedregal J. R. G., Lled\u00f3s A., Mar\u00e9chal J. D. The effect of cofactor binding on the conformational plasticity of the biological receptors in Artificial Metalloenzymes: the case study of LmrR. Frontiers in Chemistry. 2019;7 doi: 10.3389/fchem.2019.00211.", "ArticleIdList": ["10.3389/fchem.2019.00211", "PMC6467942", "31024897"]}, {"Citation": "Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 2012;64:4\u201317. doi: 10.1016/j.addr.2012.09.019.", "ArticleIdList": ["10.1016/j.addr.2012.09.019", "11259830"]}, {"Citation": "Ortega J. T., Serrano M. L., Pujol F. H., Rangel H. R. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: the main protease as molecular target. EXCLI Journal. 2020;19", "ArticleIdList": ["PMC7081067", "32210741"]}, {"Citation": "Gyebi G. A., Ogunro O. B., Adegunloye A. P., Ogunyemi O. M., Afolabi S. O. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics. 2020:1\u201313. doi: 10.1080/07391102.2020.1764868.", "ArticleIdList": ["10.1080/07391102.2020.1764868", "PMC7256353", "32367767"]}, {"Citation": "Dennis C. J., Bruno L., Rodrigo D., et al. Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection. 2020.", "ArticleIdList": ["PMC8448789", "33734021"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "7"}, {"Year": "2020", "Month": "7", "Day": "25"}, {"Year": "2020", "Month": "10", "Day": "8", "Hour": "5", "Minute": "32"}, {"Year": "2020", "Month": "10", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "9", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["33029165", "PMC7532411", "10.1155/2020/4932572"]}}]}